Nicholas T K D Dayie
Overview
Explore the profile of Nicholas T K D Dayie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kabotso D, Neglo D, Gaba S, Danyo E, Dayie A, Asantewaa A, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770495
Antimicrobial resistance (AMR) has become precarious, warranting investments in antimicrobial discovery. To investigate the antibacterial activity of rosemary essential oil (REO), alone and in combination with selected conventional antibiotics. REO...
2.
Dei-Dzeha M, Dayie N, Atiase Y, Baah B, Tetteh-Quarcoo P, Osei M, et al.
BMC Res Notes
. 2024 Dec;
17(1):362.
PMID: 39702258
Background: The nasopharynx is characterised by a rich microbial diversity, making it an important endogenous reservoir for respiratory infections. People living with diabetes (PLWD) have a high risk for acquisition...
3.
Dayie N, Nathan-Mensah F, Kotey F, Kofi Adu Tabi B, Kabotso D, Odoom A, et al.
Environ Health Insights
. 2024 Nov;
18:11786302241299369.
PMID: 39600552
Background: Antibiotic resistance (ABR) poses a critical global health challenge, necessitating its surveillance across both human and animal health sectors. This study evaluated ABR in bacteria harboured in reared inland...
4.
Arhin R, Donkor E, Slotved H, Kotey F, Dayie N
Biomed Res Int
. 2024 Sep;
2024:8368996.
PMID: 39229361
To describe the profile of , identify research gaps, and provide in-depth insights into various aspects related to the pathogen. Google Scholar, PubMed, and ScienceDirect were searched for all studies...
5.
Egyir B, Bortey A, Duedu K, Boateng G, Bekoe F, Hedidor G, et al.
Afr J Lab Med
. 2024 Sep;
13(1):2404.
PMID: 39228899
No abstract available.
6.
Armah E, Osae-Nyarko L, Idun B, Ahiabu M, Agyapong I, Kwarteng F, et al.
Genes (Basel)
. 2024 Aug;
15(8).
PMID: 39202346
The emergence and spread of extended-spectrum β-lactamase (ESBL)-producing () pose significant challenges to the treatment and control of urinary tract infections, particularly among vulnerable populations, such as the elderly living...
7.
Dayie N, Egyir B, Amoa-Owusu F, Owusu-Nyantakyi C, Adu B, Kotey F, et al.
Microorganisms
. 2024 Jun;
12(6).
PMID: 38930521
, a member of the commensal intestinal microbiota, is a significant aetiology of urinary tract infections (UTIs) and has a propensity for acquiring multidrug resistance characteristics, such as extended-spectrum beta-lactamases...
8.
Osman A, Darkwah S, Kotey F, Odoom A, Hotor P, Dayie N, et al.
Environ Health Insights
. 2024 Jun;
18():11786302241243239.
PMID: 38828046
Background: Nosocomial pathogens are known to exacerbate morbidity and mortality in contemporary critical healthcare. Hospital fomites, which include inanimate surfaces, have been identified as "breeding grounds" for pathogens that cause...
9.
Osman A, Kotey F, Odoom A, Darkwah S, Yeboah R, Dayie N, et al.
Antibiotics (Basel)
. 2023 Aug;
12(8).
PMID: 37627749
The growing threat of antibiotic resistance is a significant global health challenge that has intensified in recent years. The burden of antibiotic resistance on public health is augmented due to...
10.
Owusu F, Obeng-Nkrumah N, Gyinae E, Kodom S, Tagoe R, Kofi Adu Tabi B, et al.
Antibiotics (Basel)
. 2023 Jun;
12(6).
PMID: 37370334
Beta-lactamase (β-lactamase)-producing Gram-negative bacteria (GNB) are of public health concern due to their resistance to routine antimicrobials. We investigated the antimicrobial resistance and occurrence of carbapenemases, extended-spectrum β-lactamases (ESBLs) and...